Changes in Gene Expression of Pial Vessels of the Blood Brain Barrier during Murine Neurocysticercosis

PLoS Neglected Tropical Diseases

Volumn 7, Issue 3, 2013, Pages

  Mishra, Pramod Kumar ^a,b   Teale, Judy M ^a,b  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b UNIVERSITY OF TEXAS AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RANTES;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; CONTROLLED STUDY; DNA MICROARRAY; DOWN REGULATION; FEMALE; GENE EXPRESSION; GENE REGULATORY NETWORK; GENETIC ASSOCIATION; IMMUNOFLUORESCENCE MICROSCOPY; INTRACELLULAR SIGNALING; LASER CAPTURE MICRODISSECTION; MESOCESTOIDEA; MOUSE; NEUROCYSTICERCOSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PIA ARTERY; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION;

EID: 84875995664     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0002099     Document Type: Article

References (59)

1. Zlokovic BV, (2008) The blood-brain barrier in health and chronic neurodegenerative disorders. Neuron 57: 178-201.
2. Bechmann I, Galea I, Perry VH, (2007) "What is the blood-brain barrier (not)? Trends Immunol 28: 5-11.
3. Galea I, Bechmann I, Perry VH, (2007) What is immune privilege (not)? Trends Immunol 28: 12-18.
4. Saunders NR, Ek CJ, Habgood MD, Dziegielewska KM, (2008) Barriers in the brain: a renaissance? Trends Neurosci 31: 279-286.
5. Ransohoff RM, Kivisakk P, Kidd G, (2003) Three or more routes for leukocyte migration into the central nervous system. Nat Rev Immunol 3: 569-581.
6. Weiss N, Miller F, Cazaubon S, Couraud PO, (2009) The blood-brain barrier in brain homeostasis and neurological diseases. Biochim Biophys Acta 1788: 842-857.
7. Garcia HH, Del Brutto OH, (2005) Neurocysticercosis: updated concepts about an old disease. Lancet Neurol 4: 653-661.
8. Fleury A, Escobar A, Fragoso G, Sciutto E, Larralde C, Clinical heterogeneity of human neurocysticercosis results from complex interactions among parasite, host and environmental factors. Trans R Soc Trop Med Hyg 104: 243-250.
9. Cardenas G, Carrillo-Mezo R, Jung H, Sciutto E, Hernandez JL, et al. Subarachnoidal Neurocysticercosis non-responsive to cysticidal drugs: a case series. BMC Neurol 10: 16.
10. Alvarez JI, Teale JM, (2007) Evidence for differential changes of junctional complex proteins in murine neurocysticercosis dependent upon CNS vasculature. Brain Res 1169: 98-111.
11. Alvarez JI, Teale JM, (2008) Multiple expression of matrix metalloproteinases in murine neurocysticercosis: Implications for leukocyte migration through multiple central nervous system barriers. Brain Res 1214: 145-158.
12. Alvarez JI, Teale JM, (2007) Evidence for differential changes of junctional complex proteins in murine neurocysticercosis dependent upon CNS vasculature. Brain Res 1169: 98-111.
13. Alvarez JI, Teale JM, (2006) Breakdown of the blood brain barrier and blood-cerebrospinal fluid barrier is associated with differential leukocyte migration in distinct compartments of the CNS during the course of murine NCC. J Neuroimmunol 173: 45-55.
14. Cardona AE, Restrepo BI, Jaramillo JM, Teale JM, (1999) Development of an animal model for neurocysticercosis: immune response in the central nervous system is characterized by a predominance of gamma delta T cells. J Immunol 162: 995-1002.
15. Hunter F, Xie J, Trimble C, Bur M, Li KC, (2006) Rhodamine-RCA in vivo labeling guided laser capture microdissection of cancer functional angiogenic vessels in a murine squamous cell carcinoma mouse model. Mol Cancer 5: 5.
16. Mishra PK, Teale JM, (2012) Transcriptome analysis of the ependymal barrier during murine neurocysticercosis. J Neuroinflammation 9: 141.
17. Mishra BB, Gundra UM, Teale JM, (2011) STAT6(-)/(-) mice exhibit decreased cells with alternatively activated macrophage phenotypes and enhanced disease severity in murine neurocysticercosis. J Neuroimmunol 232: 26-34.
18. Livak KJ, Schmittgen TD, (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408.
19. Kim KS, (2008) Mechanisms of microbial traversal of the blood-brain barrier. Nat Rev Microbiol 6: 625-634.
20. Alvarez JI, Rivera J, Teale JM, (2008) Differential release and phagocytosis of tegument glycoconjugates in neurocysticercosis: implications for immune evasion strategies. PLoS Negl Trop Dis 2: e218.
21. Yamada S, DePasquale M, Patlak CS, Cserr HF, (1991) Albumin outflow into deep cervical lymph from different regions of rabbit brain. Am J Physiol 261: H1197-1204.
22. Frei K, Fontana A, (1997) Antigen presentation in the CNS. Mol Psychiatry 2: 96-98.
23. Kitaya K, Yasuo T, Yamaguchi T, Fushiki S, Honjo H, (2007) Genes regulated by interferon-gamma in human uterine microvascular endothelial cells. Int J Mol Med 20: 689-697.
24. Sana TR, Janatpour MJ, Sathe M, McEvoy LM, McClanahan TK, (2005) Microarray analysis of primary endothelial cells challenged with different inflammatory and immune cytokines. Cytokine 29: 256-269.
25. Chaudhuri A, Duan F, Morsey B, Persidsky Y, Kanmogne GD, (2008) HIV-1 activates proinflammatory and interferon-inducible genes in human brain microvascular endothelial cells: putative mechanisms of blood-brain barrier dysfunction. J Cereb Blood Flow Metab 28: 697-711.
26. Lyck R, Ruderisch N, Moll AG, Steiner O, Cohen CD, et al. (2009) Culture-induced changes in blood-brain barrier transcriptome: implications for amino-acid transporters in vivo. Journal of Cerebral Blood Flow and Metabolism 29: 1491-1502.
27. Calabria AR, Shusta EV, (2008) A genomic comparison of in vivo and in vitro brain microvascular endothelial cells. Journal of Cerebral Blood Flow and Metabolism 28: 135-148.
28. Yeom HJ, Shin KJ, Kim JS, Kim SJ, Lee S, et al. (2009) Porcine aortic endothelial cell genes responsive to selected inflammatory stimulators. J Vet Med Sci 71: 1499-1508.
29. Jong A, Wu CH, Zhou W, Chen HM, Huang SH, (2008) Infectomic analysis of gene expression profiles of human brain microvascular endothelial cells infected with Cryptococcus neoformans. J Biomed Biotechnol 2008: 375620.
30. Chaudhuri A, Yang B, Gendelman HE, Persidsky Y, Kanmogne GD, (2008) STAT1 signaling modulates HIV-1-induced inflammatory responses and leukocyte transmigration across the blood-brain barrier. Blood 111: 2062-2072.
31. Viola A, Luster AD, (2008) Chemokines and their receptors: drug targets in immunity and inflammation. Annu Rev Pharmacol Toxicol 48: 171-197.
32. Raman D, Sobolik-Delmaire T, Richmond A, (2011) Chemokines in health and disease. Exp Cell Res 317: 575-589.
33. D'Ambrosio D, Panina-Bordignon P, Sinigaglia F, (2003) Chemokine receptors in inflammation: an overview. J Immunol Methods 273: 3-13.
34. Wilson EH, Harris TH, Mrass P, John B, Tait ED, et al. (2009) Behavior of parasite-specific effector CD8+ T cells in the brain and visualization of a kinesis-associated system of reticular fibers. Immunity 30: 300-311.
35. Kitamura T, Fujishita T, Loetscher P, Revesz L, Hashida H, et al. Inactivation of chemokine (C-C motif) receptor 1 (CCR1) suppresses colon cancer liver metastasis by blocking accumulation of immature myeloid cells in a mouse model. Proc Natl Acad Sci U S A 107: 13063-13068.
36. Cardona AE, Teale JM, (2002) Gamma/delta T cell-deficient mice exhibit reduced disease severity and decreased inflammatory response in the brain in murine neurocysticercosis. J Immunol 169: 3163-3171.
37. Restrepo BI, Alvarez JI, Castano JA, Arias LF, Restrepo M, et al. (2001) Brain granulomas in neurocysticercosis patients are associated with a Th1 and Th2 profile. Infect Immun 69: 4554-4560.
38. Cardona AE, Gonzalez PA, Teale JM, (2003) CC chemokines mediate leukocyte trafficking into the central nervous system during murine neurocysticercosis: role of gamma delta T cells in amplification of the host immune response. Infect Immun 71: 2634-2642.
39. Kielian T, Barry B, Hickey WF, (2001) CXC chemokine receptor-2 ligands are required for neutrophil-mediated host defense in experimental brain abscesses. J Immunol 166: 4634-4643.
40. Hall LR, Diaconu E, Patel R, Pearlman E, (2001) CXC chemokine receptor 2 but not C-C chemokine receptor 1 expression is essential for neutrophil recruitment to the cornea in helminth-mediated keratitis (river blindness). J Immunol 166: 4035-4041.
41. Semple BD, Bye N, Ziebell JM, Morganti-Kossmann MC, (2010) Deficiency of the chemokine receptor CXCR2 attenuates neutrophil infiltration and cortical damage following closed head injury. Neurobiol Dis 40: 394-403.
42. Zhang XW, Liu Q, Wang Y, Thorlacius H, (2001) CXC chemokines, MIP-2 and KC, induce P-selectin-dependent neutrophil rolling and extravascular migration in vivo. Br J Pharmacol 133: 413-421.
43. Legler DF, Loetscher M, Roos RS, Clark-Lewis I, Baggiolini M, et al. (1998) B cell-attracting chemokine 1, a human CXC chemokine expressed in lymphoid tissues, selectively attracts B lymphocytes via BLR1/CXCR5. J Exp Med 187: 655-660.
44. Lalor SJ, Segal BM, (2010) Lymphoid chemokines in the CNS. J Neuroimmunol 224: 56-61.
45. Lee BP, Chen W, Shi H, Der SD, Forster R, et al. (2006) CXCR5/CXCL13 interaction is important for double-negative regulatory T cell homing to cardiac allografts. J Immunol 176: 5276-5283.
46. Lim HW, Hillsamer P, Kim CH, (2004) Regulatory T cells can migrate to follicles upon T cell activation and suppress GC-Th cells and GC-Th cell-driven B cell responses. J Clin Invest 114: 1640-1649.
47. Schaerli P, Willimann K, Lang AB, Lipp M, Loetscher P, et al. (2000) CXC chemokine receptor 5 expression defines follicular homing T cells with B cell helper function. J Exp Med 192: 1553-1562.
48. Huang DR, Wang J, Kivisakk P, Rollins BJ, Ransohoff RM, (2001) Absence of monocyte chemoattractant protein 1 in mice leads to decreased local macrophage recruitment and antigen-specific T helper cell type 1 immune response in experimental autoimmune encephalomyelitis. J Exp Med 193: 713-726.
49. Izikson L, Klein RS, Charo IF, Weiner HL, Luster AD, (2000) Resistance to experimental autoimmune encephalomyelitis in mice lacking the CC chemokine receptor (CCR)2. J Exp Med 192: 1075-1080.
50. Fife BT, Huffnagle GB, Kuziel WA, Karpus WJ, (2000) CC chemokine receptor 2 is critical for induction of experimental autoimmune encephalomyelitis. J Exp Med 192: 899-905.
51. Qian BZ, Li J, Zhang H, Kitamura T, Zhang J, et al. (2011) CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis. Nature 475: 222-225.
52. Kawai T, Seki M, Hiromatsu K, Eastcott JW, Watts GF, et al. (1999) Selective diapedesis of Th1 cells induced by endothelial cell RANTES. J Immunol 163: 3269-3278.
53. Roth SJ, Diacovo TG, Brenner MB, Rosat JP, Buccola J, et al. (1998) Transendothelial chemotaxis of human alpha/beta and gamma/delta T lymphocytes to chemokines. Eur J Immunol 28: 104-113.
54. Glass WG, Lim JK, Cholera R, Pletnev AG, Gao JL, et al. (2005) Chemokine receptor CCR5 promotes leukocyte trafficking to the brain and survival in West Nile virus infection. J Exp Med 202: 1087-1098.
55. Asensio VC, Lassmann S, Pagenstecher A, Steffensen SC, Henriksen SJ, et al. (1999) C10 is a novel chemokine expressed in experimental inflammatory demyelinating disorders that promotes recruitment of macrophages to the central nervous system. Am J Pathol 154: 1181-1191.
56. Coelho AL, Schaller MA, Benjamim CF, Orlofsky AZ, Hogaboam CM, et al. (2007) The chemokine CCL6 promotes innate immunity via immune cell activation and recruitment. J Immunol 179: 5474-5482.
57. Kitamura T, Fujishita T, Loetscher P, Revesz L, Hashida H, et al. (2010) Inactivation of chemokine (C-C motif) receptor 1 (CCR1) suppresses colon cancer liver metastasis by blocking accumulation of immature myeloid cells in a mouse model. Proc Natl Acad Sci U S A 107: 13063-13068.
58. Zhao X, Sato A, Dela Cruz CS, Linehan M, Luegering A, et al. (2003) CCL9 is secreted by the follicle-associated epithelium and recruits dome region Peyer's patch CD11b+ dendritic cells. J Immunol 171: 2797-2803.
59. Andrew DP, Ruffing N, Kim CH, Miao W, Heath H, et al. (2001) C-C chemokine receptor 4 expression defines a major subset of circulating nonintestinal memory T cells of both Th1 and Th2 potential. J Immunol 166: 103-111.